Clinical Trial Update: Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2b trial of KBP-5074 in patients with uncontrolled hypertension and advanced chronic kidney disease has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• KBP-5074 (KBP-5074)

Snippet

Sponsor: KBP Biosciences | Conditions: Chronic Kidney Diseases, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2024-03-21